Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development
12 February 2024
- Notice of results Press Release, Financial Results 09 July 2025 Notice of results
- Supporting communities globally: Highlights from our 2025 Global Volunteer Campaign Story, Responsibility 03 July 2025 Supporting communities globally: Highlights from our 2025 Global Volunteer Campaign
- Meet Farah Alasali, Senior Officer in our Social Responsibility team based in Jordan. Hear what she has to say about life at Hikma. #OwnYourCareer Story, Life at Hikma 02 July 2025 Meet Farah Alasali, Senior Officer in our Social Responsibility team based in Jordan. Hear what she has to say about life at Hikma. #OwnYourCareer
- Hikma receives FDA approval for TYZAVANTM (Vancomycin Injection, USP) in the US Press Release, Product 02 July 2025 Hikma receives FDA approval for TYZAVANTM (Vancomycin Injection, USP) in the US
Related content